| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Constanze Breithaupt, Anna Schubart, Hilke Zander, Arne Skerra, Robert Huber, Christopher Linington, Uwe Jaco. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences of the United States of America. vol 100. issue 16. 2003-10-03. PMID:12874380. |
the immunopathogenesis of demyelination in multiple sclerosis involves an autoantibody response to myelin oligodendrocyte glycoprotein (mog), a type i transmembrane protein located at the surface of cns myelin. |
2003-10-03 |
2023-08-12 |
Not clear |
| C A Halfpenny, N J Scoldin. Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro. Journal of neuroimmunology. vol 139. issue 1-2. 2003-08-13. PMID:12799015. |
limited intrinsic myelin repair occurs in multiple sclerosis (ms), mediated by oligodendrocyte progenitors that divide and migrate into demyelinated lesions. |
2003-08-13 |
2023-08-12 |
Not clear |
| Milos Markovic, Vladimir Trajkovic, Jelena Drulovic, Sarlota Mesaros, Nebojsa Stojsavljevic, Irena Dujmovic, Marija Mostarica Stojkovi. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients. Journal of the neurological sciences. vol 211. issue 1-2. 2003-07-21. PMID:12767500. |
antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients. |
2003-07-21 |
2023-08-12 |
Not clear |
| Milos Markovic, Vladimir Trajkovic, Jelena Drulovic, Sarlota Mesaros, Nebojsa Stojsavljevic, Irena Dujmovic, Marija Mostarica Stojkovi. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients. Journal of the neurological sciences. vol 211. issue 1-2. 2003-07-21. PMID:12767500. |
antibodies against myelin oligodendrocyte glycoprotein (mog) mediate demyelination in experimental autoimmune encephalomyelitis (eae) in different animal species and are implicated in the immunopathogenesis of multiple sclerosis (ms). |
2003-07-21 |
2023-08-12 |
Not clear |
| Thomas Berger, Paul Rubner, Franz Schautzer, Robert Egg, Hanno Ulmer, Irmgard Mayringer, Erika Dilitz, Florian Deisenhammer, Markus Reind. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. The New England journal of medicine. vol 349. issue 2. 2003-07-14. PMID:12853586. |
we investigated whether the presence of serum antibodies against myelin oligodendrocyte glycoprotein (mog) and myelin basic protein (mbp) in patients with a clinically isolated syndrome predicts the interval to conversion to clinically definite multiple sclerosis. |
2003-07-14 |
2023-08-12 |
Not clear |
| Anna Jurewicz, Mariola Matysiak, Krzysztof Tybor, Krzysztof Selma. TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3. Brain : a journal of neurology. vol 126. issue Pt 6. 2003-07-01. PMID:12764057. |
this is the first evidence that a jnk-3 isoform is involved in oligodendrocyte death and might have significant importance in designing new molecules to protect hols demise in multiple sclerosis. |
2003-07-01 |
2023-08-12 |
human |
| Jacques Penderis, Simon A Shields, Robin J M Frankli. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain : a journal of neurology. vol 126. issue Pt 6. 2003-07-01. PMID:12764059. |
it has been hypothesized that the progressive failure of remyelination in chronic multiple sclerosis is, in part, the consequence of repeated episodes of demyelination at the same site, eventually depleting oligodendrocyte progenitor cells (opcs) and exhausting the remyelinating capacity. |
2003-07-01 |
2023-08-12 |
rat |
| Mieke Buntinx, Piet Stinissen, Paul Steels, Marcel Ameloot, Jef Rau. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. Critical reviews in immunology. vol 22. issue 5-6. 2003-06-27. PMID:12803318. |
immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. |
2003-06-27 |
2023-08-12 |
Not clear |
| Karolina Wosik, Jack Antel, Tanja Kuhlmann, Wolfgang Brück, Bernard Massie, Josephine Nalbantogl. Oligodendrocyte injury in multiple sclerosis: a role for p53. Journal of neurochemistry. vol 85. issue 3. 2003-06-17. PMID:12694389. |
oligodendrocyte injury in multiple sclerosis: a role for p53. |
2003-06-17 |
2023-08-12 |
human |
| Karolina Wosik, Jack Antel, Tanja Kuhlmann, Wolfgang Brück, Bernard Massie, Josephine Nalbantogl. Oligodendrocyte injury in multiple sclerosis: a role for p53. Journal of neurochemistry. vol 85. issue 3. 2003-06-17. PMID:12694389. |
multiple sclerosis (ms) is a neurological disorder characterized by myelin destruction and a variable degree of oligodendrocyte death. |
2003-06-17 |
2023-08-12 |
human |
| Ikuo Tsunoda, Robert S Fujinam. Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination. Springer seminars in immunopathology. vol 24. issue 2. 2003-06-05. PMID:12503060. |
the primary target in multiple sclerosis (ms) is believed to be either myelin itself (myelinopathy) or the myelin-forming cell, the oligodendrocyte (oligodendrogliopathy). |
2003-06-05 |
2023-08-12 |
human |
| Annegret Van der Aa, Niels Hellings, Claude C A Bernard, Jef Raus, Piet Stinisse. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. Journal of neuroimmunology. vol 137. issue 1-2. 2003-06-03. PMID:12667661. |
functional properties of myelin oligodendrocyte glycoprotein-reactive t cells in multiple sclerosis patients and controls. |
2003-06-03 |
2023-08-12 |
human |
| Alison R Jennings, Yaowanuj Kirilak, William M Carrol. In situ characterisation of oligodendrocyte progenitor cells in adult mammalian optic nerve. Journal of neurocytology. vol 31. issue 1. 2003-05-27. PMID:12652085. |
the identification and characterisation of oligodendrocyte progenitors in situ in fixed tissue sections should help the understanding of their role in the adult cns and in disease such as multiple sclerosis. |
2003-05-27 |
2023-08-12 |
Not clear |
| Jorge Correale, María de los Milagros Bassani Molina. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes. Journal of neuroimmunology. vol 136. issue 1-2. 2003-05-09. PMID:12620656. |
cd4(+) t-cell lines (tcls) from patients with clinically isolated syndromes (cis) were selected with purified human myelin basic protein (mbp) and recombinant human myelin oligodendrocyte glycoprotein (rhmog), at onset of neurological symptoms and when patients developed clinically definite multiple sclerosis (cdms). |
2003-05-09 |
2023-08-12 |
human |
| F BARONTIN. [Behavior of oligodendroglia in multiple sclerosis]. Rassegna di studi psichiatrici. vol 43. issue 3. 2003-05-01. PMID:13204654. |
[behavior of oligodendroglia in multiple sclerosis]. |
2003-05-01 |
2023-08-12 |
Not clear |
| Anna Lobell, Robert Weissert, Sana Eltayeb, Katrien L de Graaf, Judit Wefer, Maria K Storch, Hans Lassmann, Hans Wigzell, Tomas Olsso. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response. Journal of immunology (Baltimore, Md. : 1950). vol 170. issue 4. 2003-04-25. PMID:12574345. |
additional myelin proteins, such as myelin oligodendrocyte glycoprotein (mog), may be important in multiple sclerosis. |
2003-04-25 |
2023-08-12 |
rat |
| Gwen S Scott, Laszlo Virág, Csaba Szabó, D Craig Hoope. Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia. vol 41. issue 2. 2003-04-02. PMID:12509801. |
oligodendrocyte loss is a characteristic feature of several cns disorders, including multiple sclerosis (ms) and spinal cord injury. |
2003-04-02 |
2023-08-12 |
mouse |
| Corinna Lappe-Siefke, Sandra Goebbels, Michel Gravel, Eva Nicksch, John Lee, Peter E Braun, Ian R Griffiths, Klaus-Armin Nav. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nature genetics. vol 33. issue 3. 2003-03-25. PMID:12590258. |
oligodendrocyte dysfunction, such as that in multiple sclerosis lesions, may suffice to cause secondary axonal loss. |
2003-03-25 |
2023-08-12 |
mouse |
| A Kennel De March, M De Bouwerie, M N Kolopp-Sarda, G C Faure, M C Béné, C C A Bernar. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. Journal of neuroimmunology. vol 135. issue 1-2. 2003-03-20. PMID:12576231. |
anti-myelin oligodendrocyte glycoprotein b-cell responses in multiple sclerosis. |
2003-03-20 |
2023-08-12 |
Not clear |
| A Kennel De March, M De Bouwerie, M N Kolopp-Sarda, G C Faure, M C Béné, C C A Bernar. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. Journal of neuroimmunology. vol 135. issue 1-2. 2003-03-20. PMID:12576231. |
humoral auto-immunity to the myelin oligodendrocyte glycoprotein (mog) is likely involved in the pathogenesis of multiple sclerosis (ms). |
2003-03-20 |
2023-08-12 |
Not clear |